Insider · CIK 0001380022

NARACHI MICHAEL

Reports to the SEC for 4 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001380022

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+7,751 sh	—	—	40,441
2026-05-14	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,058
2025-05-15	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,740 sh	—	—	32,690
2025-05-15	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,787
2024-06-18	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,345 sh	—	—	26,950
2024-06-18	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,900 sh	—	—	9,900
2023-06-07	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,860 sh	—	—	21,605
2023-06-07	RAREUltragenyx Pharmaceutical Inc. · Common StockA Award	Director	AAward	+7,110 sh	—	—	7,110
2022-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,300 sh	—	—	17,745
2022-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,245 sh	—	—	6,245
2021-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+2,145 sh	—	—	14,445
2021-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,125 sh	—	—	4,125
2020-06-26	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+2,550 sh	—	—	12,300
2020-06-26	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,250 sh	—	—	4,250
2019-06-11	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,000 sh	—	—	9,750
2019-06-11	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2018-06-19	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,000 sh	—	—	6,750
2018-06-19	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2017-10-13	Orexigen Therapeutics, Inc.Restricted Stock Unit (RSU)A Award	Director, CEO & President	AAward	+252K sh	—	—	252,000
2017-06-22	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+1,875 sh	—	—	3,750
2017-06-22	RAREUltragenyx Pharmaceutical Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2017-05-31	Orexigen Therapeutics, Inc.A Award	Director, CEO & President	AAward	+626 sh	$1.55	+$970.3	8,356
2017-02-03	Orexigen Therapeutics, Inc.Stock OptionA Award	Director, CEO & President	AAward	+315K sh	—	—	315,000
2017-02-03	Orexigen Therapeutics, Inc.Stock OptionA Award	Director, CEO & President	AAward	+158K sh	—	—	157,500
2016-11-30	Orexigen Therapeutics, Inc.A Award	Director, CEO & President	AAward	+802 sh	$1.67	+$1,339.34	6,312
2016-07-12	Orexigen Therapeutics, Inc.Stock OptionA Award	Director, CEO & President	AAward	+525K sh	—	—	525,000
2016-07-12	Orexigen Therapeutics, Inc.Stock OptionA Award	Director, CEO & President	AAward	+105K sh	—	—	105,000
2016-07-12	Orexigen Therapeutics, Inc.Stock OptionA Award	Director, CEO & President	AAward	+315K sh	—	—	315,000
2016-07-12	Orexigen Therapeutics, Inc.Stock OptionA Award	Director, CEO & President	AAward	+63K sh	—	—	63,000
2016-06-09	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+1,875 sh	—	—	1,875
2016-06-09	RAREUltragenyx Pharmaceutical Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2016-05-31	Orexigen Therapeutics, Inc.A Award	Director, CEO & President	AAward	+8,777 sh	$0.34	+$2,984.18	69,285
2016-02-02	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director, CEO & President	AAward	+700K sh	—	—	700,000
2016-02-02	Orexigen Therapeutics, Inc.Performance Stock UnitsA Award	Director, CEO & President	AAward	+800K sh	—	—	800,000
2015-11-30	Orexigen Therapeutics, Inc.A Award	Director, CEO & President	AAward	+1,761 sh	$2.03	+$3,574.83	60,508
2015-06-18	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-06-04	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)A Award	Director	AAward	+10K sh	—	—	50,000
2015-05-29	Orexigen Therapeutics, Inc.A Award	Director, CEO & President	AAward	+721 sh	$4.17	+$3,006.57	58,747
2015-02-20	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2015-02-03	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director, CEO & President	AAward	+635K sh	—	—	635,150
2014-09-15	Orexigen Therapeutics, Inc.P Purchase	Director, CEO & President	PPurchase	+50K sh	$4.78	+$239K	58,026
2014-02-07	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director, CEO & President	AAward	+674K sh	—	—	673,500
2014-02-04	Eiger BioPharmaceuticals, Inc.P Purchase	Director	PPurchase	+62.5K sh	$8.00	+$500K	62,500
2013-11-29	Orexigen Therapeutics, Inc.A Award	Director, CEO & President	AAward	+3,980 sh	$5.34	+$21.3K	3,980
2013-05-23	AMAG PHARMACEUTICALS, INC.A Award	Director	AAward	+3,800 sh	—	—	23,900
2013-05-23	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+7,600 sh	—	—	7,600
2013-02-15	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	Director, CEO & President	AAward	+555K sh	—	—	555,000
2012-07-17	Orexigen Therapeutics, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+124K sh	$1.66	+$206K	124,238
2012-07-17	Orexigen Therapeutics, Inc.S Sale	Director, CEO & President	SSale	−124K sh	$7.66	−$952K	0
2012-07-17	Orexigen Therapeutics, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+25.8K sh	$1.70	+$43.8K	25,762

Recent filings

Accepted (ET)
May 184
NARACHI MICHAEL0001380022-26-000002
SEC(opens sec.gov)
May 194
NARACHI MICHAEL0000950170-25-074665
SEC(opens sec.gov)
Jun 204
NARACHI MICHAEL0000950170-24-075487
SEC(opens sec.gov)
Jun 94
NARACHI MICHAEL0001209191-23-035688
SEC(opens sec.gov)
Jun 284
NARACHI MICHAEL0001209191-22-039565
SEC(opens sec.gov)
Jun 284
NARACHI MICHAEL0001209191-21-043538
SEC(opens sec.gov)
Jun 304
NARACHI MICHAEL0001209191-20-039407
SEC(opens sec.gov)
Jun 134
NARACHI MICHAEL0001209191-19-036816
SEC(opens sec.gov)
Jun 204
NARACHI MICHAEL0001209191-18-038857
SEC(opens sec.gov)
Oct 174
NARACHI MICHAEL0001209191-17-057217
SEC(opens sec.gov)
Jun 224
Ultragenyx Pharmaceutical Inc.0001209191-17-041474
SEC(opens sec.gov)

Companies

Address

C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT

NOVATO, CA, 94949